Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 5/2009

01-05-2009 | Letter

Left ventricular diastolic function and exercise capacity in diabetes. Reply to Brassard P, Poirier P [letter]

Authors: S. Gusso, P. Hofman, S. Lalande, W. Cutfield, E. Robinson, J. C. Baldi

Published in: Diabetologia | Issue 5/2009

Login to get access

Excerpt

To the Editor: We thank Drs Brassard and Poirier for their valuable comments on our recent publication in Diabetologia [1, 2]. We found that female adolescent patients with type 1 and type 2 diabetes had an impaired stroke volume response to submaximal exercise and reduced maximal oxygen consumption compared with non-diabetic controls. We suggested that these impairments might be partially attributed to early cardiac impairments, which are observed in diabetic adults, including altered myocardial and left ventricular (LV) filling characteristics [3, 4]. …
Literature
1.
Gusso S, Hofman P, Lalande S, Cutfield W, Robinson E, Baldi JC (2008) Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia 51:1317–1320PubMedCrossRef
2.
3.
Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5–10PubMedCrossRef
4.
Fraser GE, Luke R, Thompson S, Smith H, Carter S, Sharpe N (1995) Comparison of echocardiographic variables between type I diabetics and normal controls. Am J Cardiol 75:141–145PubMedCrossRef
5.
Poirier P, Garneau C, Bogaty P et al (2000) Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 85:473–477PubMedCrossRef
6.
Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS (1995) Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 8:221–228PubMedCrossRef
7.
Missouris CG, Forbat SM, Singer DR, Markandu ND, Underwood R, MacGregor GA (1996) Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 14:1005–1010PubMed
8.
Sandstede J, Lipke C, Beer M et al (2000) Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 10:438–442PubMedCrossRef
Metadata
Title
Left ventricular diastolic function and exercise capacity in diabetes. Reply to Brassard P, Poirier P [letter]
Authors
S. Gusso
P. Hofman
S. Lalande
W. Cutfield
E. Robinson
J. C. Baldi
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1303-1

Other articles of this Issue 5/2009

Diabetologia 5/2009 Go to the issue

For Debate

Glucose allostasis: Emperor’s new clothes?

Article

Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population

Article

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

Article

n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet

Article

Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats

Review

Regulation of insulin secretion: a matter of phase control and amplitude modulation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits